Monsenso A/S (CPH:MONSO)
Denmark
· Delayed Price · Currency is DKK 0.2560
-0.0080 (-3.03%)
May 8, 2025, 1:19 PM CET
Monsenso Revenue
In the year 2024, Monsenso had annual revenue of 11.17M DKK with 16.01% growth. Monsenso had revenue of 5.64M in the half year ending December 31, 2024, with 56.09% growth.
Revenue
11.17M
Revenue Growth
+16.01%
P/S Ratio
1.53
Revenue / Employee
858.85K
Employees
13
Market Cap
17.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.17M | 1.54M | 16.01% |
| Dec 31, 2023 | 9.62M | 3.41M | 54.90% |
| Dec 31, 2022 | 6.21M | -930.00K | -13.02% |
| Dec 31, 2021 | 7.14M | -1.92M | -21.19% |
| Dec 31, 2020 | 9.06M | 283.00K | 3.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 290.40B |
| Coloplast | 27.79B |
| Genmab | 21.53B |
| Demant | 22.42B |
| ALK-Abelló | 5.71B |
| Zealand Pharma | 62.69M |
| Ambu A/S | 5.65B |
| H. Lundbeck | 22.00B |